These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22552548)

  • 1. The effects of the carboxyl-terminus amino acids of the Shiga toxin B-subunit on retrograde transport.
    Liu D; Fan Y; Li J; Gao X; Hao M; Xue H; Tai G
    Mol Med Rep; 2012 Jul; 6(1):220-6. PubMed ID: 22552548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trafficking of Shiga toxin/Shiga-like toxin-1 in human glomerular microvascular endothelial cells and human mesangial cells.
    Warnier M; Römer W; Geelen J; Lesieur J; Amessou M; van den Heuvel L; Monnens L; Johannes L
    Kidney Int; 2006 Dec; 70(12):2085-91. PubMed ID: 17063173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Shiga toxin subunit association by using hybrid A polypeptides and site-specific mutagenesis.
    Jemal C; Haddad JE; Begum D; Jackson MP
    J Bacteriol; 1995 Jun; 177(11):3128-32. PubMed ID: 7768810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrograde transport from the Golgi complex to the ER of both Shiga toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and cAMP.
    Sandvig K; Ryd M; Garred O; Schweda E; Holm PK; van Deurs B
    J Cell Biol; 1994 Jul; 126(1):53-64. PubMed ID: 8027186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrograde transport of KDEL-bearing B-fragment of Shiga toxin.
    Johannes L; Tenza D; Antony C; Goud B
    J Biol Chem; 1997 Aug; 272(31):19554-61. PubMed ID: 9235960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analysis of the Shiga toxin and Shiga-like toxin type II variant binding subunits by using site-directed mutagenesis.
    Jackson MP; Wadolkowski EA; Weinstein DL; Holmes RK; O'Brien AD
    J Bacteriol; 1990 Feb; 172(2):653-8. PubMed ID: 2404947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of three amino acid residues in the B subunit of Shiga toxin and Shiga-like toxin type II that are essential for holotoxin activity.
    Perera LP; Samuel JE; Holmes RK; O'Brien AD
    J Bacteriol; 1991 Feb; 173(3):1151-60. PubMed ID: 1991714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of HIV-1 Nef on retrograde transport from the plasma membrane to the endoplasmic reticulum.
    Johannes L; Pezo V; Mallard F; Tenza D; Wiltz A; Saint-Pol A; Helft J; Antony C; Benaroch P
    Traffic; 2003 May; 4(5):323-32. PubMed ID: 12713660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Entry of Shiga toxin into cells.
    Sandvig K; Dubinina E; Garred O; Prydz K; Kozlov JV; Hansen SH; Van Deurs B
    Zentralbl Bakteriol; 1993 Apr; 278(2-3):296-305. PubMed ID: 8347933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passage through the Golgi is necessary for Shiga toxin B subunit to reach the endoplasmic reticulum.
    McKenzie J; Johannes L; Taguchi T; Sheff D
    FEBS J; 2009 Mar; 276(6):1581-95. PubMed ID: 19220458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analyzing of expression of novel polypeptide complexes consisting of Shiga toxin B subunit and Adherence Fimbriae of Escherichia coli based on in silico modeling.
    Noroozian Z; Oloomi M; Bouzari S
    J Mol Model; 2012 Sep; 18(9):4131-9. PubMed ID: 22527278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric Adenocarcinomas Express the Glycosphingolipid Gb3/CD77: Targeting of Gastric Cancer Cells with Shiga Toxin B-Subunit.
    Geyer PE; Maak M; Nitsche U; Perl M; Novotny A; Slotta-Huspenina J; Dransart E; Holtorf A; Johannes L; Janssen KP
    Mol Cancer Ther; 2016 May; 15(5):1008-17. PubMed ID: 26826119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Live attenuated Shigella dysenteriae type 1 vaccine strains overexpressing shiga toxin B subunit.
    Wu T; Grassel C; Levine MM; Barry EM
    Infect Immun; 2011 Dec; 79(12):4912-22. PubMed ID: 21969003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ether lipid precursor hexadecylglycerol protects against Shiga toxins.
    Bergan J; Skotland T; Lingelem AB; Simm R; Spilsberg B; Lindbäck T; Sylvänne T; Simolin H; Ekroos K; Sandvig K
    Cell Mol Life Sci; 2014 Nov; 71(21):4285-300. PubMed ID: 24740796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential recognition of lipid domains by two Gb3-binding lectins.
    Schubert T; Sych T; Madl J; Xu M; Omidvar R; Patalag LJ; Ries A; Kettelhoit K; Brandel A; Mely Y; Steinem C; Werz DB; Thuenauer R; Römer W
    Sci Rep; 2020 Jun; 10(1):9752. PubMed ID: 32546842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shiga toxins.
    Bergan J; Dyve Lingelem AB; Simm R; Skotland T; Sandvig K
    Toxicon; 2012 Nov; 60(6):1085-107. PubMed ID: 22960449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the disulfide bond in Shiga toxin A-chain for toxin entry into cells.
    Garred O; Dubinina E; Polesskaya A; Olsnes S; Kozlov J; Sandvig K
    J Biol Chem; 1997 Apr; 272(17):11414-9. PubMed ID: 9111051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of processing and intracellular transport for optimal toxicity of Shiga toxin and toxin mutants.
    Garred O; Dubinina E; Holm PK; Olsnes S; van Deurs B; Kozlov JV; Sandvig K
    Exp Cell Res; 1995 May; 218(1):39-49. PubMed ID: 7737376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insertion and orientation of a synthetic peptide representing the C-terminus of the A1 domain of Shiga toxin into phospholipid membranes.
    Saleh MT; Ferguson J; Boggs JM; Gariépy J
    Biochemistry; 1996 Jul; 35(29):9325-34. PubMed ID: 8755710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification in media composition to obtain secretory production of STxB-based vaccines using Escherichia coli.
    Sadraeian M; Ghoshoon MB; Mohkam M; Karimi Z; Rasoul-Amini S; Ghasemi Y
    Virol Sin; 2013 Feb; 28(1):43-8. PubMed ID: 23329470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.